Since the FDA’s groundbreaking approval of Zarxio in 2015, the US biosimilars market has surged to 67 approvals across 18 ...

The approvals for Celltrion's denosumab-bmwo (Stoboclo and Osenvelt) mark the third FDA green light for a biosimilar to treat ...

The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their ...

On this episode of Not So Different, we explore the Federal Trade Commission’s (FTC) second interim report on pharmacy ...

Number 4: Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its ...

Patients with non-small cell lung cancer (NSCLC) taking bevacizumab biosimilars demonstrated equivalent therapeutic efficacy ...

Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart biosimilar.